drugset / Trial / NCT01435577

Intravenous Tapentadol in Post-Bunionectomy Pain

NCT01435577

Phase 2 Completed 177 enrolled Grünenthal GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this trial is to established the safety and efficacy of multiple dose treatment with tapentadol IV in an adult population with moderate to severe pain following bunionectomy.

Timeline

Start
2011-09
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Tapentadol Small molecule 30 mg Intravenous

Indications